Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations

Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold shares to cover income tax withholding obligations related to vesting restricted stock units.

Summary

• Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold shares of common stock on April 28, 2025, and April 30, 2025.
• The sales were executed to cover income tax withholding obligations upon the vesting of restricted stock units (RSUs).
• On April 28, 2025, 4,090 shares were sold at a price of $3.17 per share.
• On April 30, 2025, 27,472 shares were sold at a price of $3 per share.
• Following these transactions, Bergstrom beneficially owns 583,490 shares of Relay Therapeutics, Inc., including shares underlying RSUs.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover tax obligations) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Key Dates

Keywords

Relay Therapeutics, RLAY, Form 4, Insider Trading, Stock Sale, Bergstrom, Restricted Stock Units, Tax Obligations